This working group will focus on methods for the prediction of biological consequences of cancer variants, and practices for evaluating robustness and confidence of these predictions. Ultimately, this focus should lead to guidelines, standards, and implementations in support of the use of these predictions as evidence for variant interpretations.
Meeting times and locations to be determined
Working Group Leads
- Santiago Gonzalez
- Peter Rogan
- Ioannis Vlachos